Glimisave MV 1.3F Tablet SR is a medication classified as an anti-diabetic drug. It is specifically designed to treat type 2 diabetes mellitus in adults. This condition affects how the body processes glucose, leading to symptoms like increased thirst and frequent urination. People with type 2 diabetes either do not produce enough insulin or their body is resistant to its effects. The tablet is a combination of three drugs - Glimepiride, Metformin, and Voglibose - which work together to regulate blood sugar levels and keep diabetes under control.

It is crucial to take Glimisave MV 1.3F Tablet SR with food to avoid stomach issues. Your doctor will determine the appropriate dosage based on your condition. It is essential to adhere to the prescribed regimen and not stop the medication abruptly, as this could cause a sudden spike in blood sugar levels, increasing the risk of complications like eye damage, kidney issues, and nerve problems. Common side effects of this medication may include hypoglycemia, taste changes, nausea, diarrhea, headache, and stomach pain, among others. These side effects usually subside over time but should be discussed with your doctor if they persist.

It is important to note that Glimisave MV 1.3F Tablet SR is not suitable for individuals with type 1 diabetes mellitus, severe kidney or liver disease, or diabetic ketoacidosis. Precautions should be taken if you have a history of heart disease, and pregnant or breastfeeding women should consult their doctor before using this medication. Regular monitoring of blood sugar levels and potential blood tests are recommended to assess the medication's efficacy and any impact on liver function. Your lifestyle habits, including diet, exercise, and weight management, play a crucial role in managing diabetes alongside this medication.